Article
Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida species.
Antimicrobial agents and chemotherapy - 1 Jan 2013
Astvad Karen M, Perlin David S, Johansen Helle K, Jensen Rasmus H, Arendrup Maiken C
Abstract excerpt
FKS mutant isolates associated with breakthrough or failure cases are emerging in clinical settings. Discrimination of these from wild-type (wt) isolates in a routine laboratory setting is complicated. We evaluated the ability of caspofungin MIC determination using the new Vitek 2 AST-Y06 yeast susceptibility card to correctly identify the fks mutants from wt isolates and compared the performance to those of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.